337 related articles for article (PubMed ID: 29850609)
1. Assessment of Vitamin D-Binding Protein and Early Prediction of Nephropathy in Type 2 Saudi Diabetic Patients.
Fawzy MS; Abu AlSel BT
J Diabetes Res; 2018; 2018():8517929. PubMed ID: 29850609
[TBL] [Abstract][Full Text] [Related]
2. Urinary monocyte chemoattractant protein-1 and vitamin D-binding protein as biomarkers for early detection of diabetic nephropathy in type 2 diabetes mellitus.
Shoukry A; Bdeer Sel-A; El-Sokkary RH
Mol Cell Biochem; 2015 Oct; 408(1-2):25-35. PubMed ID: 26104579
[TBL] [Abstract][Full Text] [Related]
3. Association of Circulating Vitamin D, VDBP, and Vitamin D Receptor Expression with Severity of Diabetic Nephropathy in a Group of Saudi Type 2 Diabetes Mellitus Patients.
Fawzy MS; Beladi FIA
Clin Lab; 2018 Oct; 64(10):1623-1633. PubMed ID: 30336516
[TBL] [Abstract][Full Text] [Related]
4. Urinary heme oxygenase-1 as a potential biomarker for early diabetic nephropathy.
Li Z; Xu Y; Liu X; Nie Y; Zhao Z
Nephrology (Carlton); 2017 Jan; 22(1):58-64. PubMed ID: 26733347
[TBL] [Abstract][Full Text] [Related]
5. Vitamin D-Binding Protein Clearance Ratio Is Significantly Associated with Glycemic Status and Diabetes Complications in a Predominantly Vitamin D-Deficient Population.
Abdella NA; Mojiminiyi OA
J Diabetes Res; 2018; 2018():6239158. PubMed ID: 29888290
[TBL] [Abstract][Full Text] [Related]
6. Elevated urinary level of vitamin D-binding protein as a novel biomarker for diabetic nephropathy.
Tian XQ; Zhao LM; Ge JP; Zhang Y; Xu YC
Exp Ther Med; 2014 Feb; 7(2):411-416. PubMed ID: 24396416
[TBL] [Abstract][Full Text] [Related]
7. Urinary podocalyxin positive-element occurs in the early stage of diabetic nephropathy and is correlated with a clinical diagnosis of diabetic nephropathy.
Ye H; Bai X; Gao H; Li L; Wu C; Sun X; Zhang C; Shen Y; Zhang J; Lu Z
J Diabetes Complications; 2014; 28(1):96-100. PubMed ID: 24075693
[TBL] [Abstract][Full Text] [Related]
8. Zinc alpha 2 glycoprotein as an early biomarker of diabetic nephropathy in patients with type 2 diabetes mellitus.
Elsheikh M; Elhefnawy KA; Emad G; Ismail M; Borai M
J Bras Nefrol; 2019; 41(4):509-517. PubMed ID: 30897192
[TBL] [Abstract][Full Text] [Related]
9. Assessment of two novel renal tubular proteins in type 2 diabetic patients with nephropathy.
Abdel Ghafar MT; Shalaby KH; Okda HI; Abo El Gheit RE; Soliman NA; Keshk WA
J Investig Med; 2020 Mar; 68(3):748-755. PubMed ID: 31722957
[TBL] [Abstract][Full Text] [Related]
10. Utility of urinary biomarkers as a diagnostic tool for early diabetic nephropathy in patients with type 2 diabetes mellitus.
Vijay S; Hamide A; Senthilkumar GP; Mehalingam V
Diabetes Metab Syndr; 2018 Sep; 12(5):649-652. PubMed ID: 29673928
[TBL] [Abstract][Full Text] [Related]
11. Assessing urinary levels of IL-18, NGAL and albumin creatinine ratio in patients with diabetic nephropathy.
Sueud T; Hadi NR; Abdulameer R; Jamil DA; Al-Aubaidy HA
Diabetes Metab Syndr; 2019; 13(1):564-568. PubMed ID: 30641767
[TBL] [Abstract][Full Text] [Related]
12. Periostin as a tissue and urinary biomarker of renal injury in type 2 diabetes mellitus.
Satirapoj B; Tassanasorn S; Charoenpitakchai M; Supasyndh O
PLoS One; 2015; 10(4):e0124055. PubMed ID: 25884625
[TBL] [Abstract][Full Text] [Related]
13. Correlation between urine vitamin D
Huang Y; Chen S; Dai Q; Zhang H; Liu Y
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2023 Jan; 48(1):40-48. PubMed ID: 36935176
[TBL] [Abstract][Full Text] [Related]
14. Identification of urinary soluble E-cadherin as a novel biomarker for diabetic nephropathy.
Jiang H; Guan G; Zhang R; Liu G; Cheng J; Hou X; Cui Y
Diabetes Metab Res Rev; 2009 Mar; 25(3):232-41. PubMed ID: 19177462
[TBL] [Abstract][Full Text] [Related]
15. Elevated urinary D-lactate levels in patients with diabetes and microalbuminuria.
Chou CK; Lee YT; Chen SM; Hsieh CW; Huang TC; Li YC; Lee JA
J Pharm Biomed Anal; 2015 Dec; 116():65-70. PubMed ID: 26166004
[TBL] [Abstract][Full Text] [Related]
16. Clinical significance and different levels of urinary monocyte chemoattractant protein-1 in type 2 diabetes mellitus.
Wang QY; Chen FQ
Diabetes Res Clin Pract; 2009 Feb; 83(2):215-9. PubMed ID: 19097668
[TBL] [Abstract][Full Text] [Related]
17. Adipokine zinc-alpha-2-glycoprotein as a novel urinary biomarker presents earlier than microalbuminuria in diabetic nephropathy.
Wang Y; Li YM; Zhang S; Zhao JY; Liu CY
J Int Med Res; 2016 Apr; 44(2):278-86. PubMed ID: 26857862
[TBL] [Abstract][Full Text] [Related]
18. Higher serum betatrophin level in type 2 diabetes subjects is associated with urinary albumin excretion and renal function.
Chen CC; Susanto H; Chuang WH; Liu TY; Wang CH
Cardiovasc Diabetol; 2016 Jan; 15():3. PubMed ID: 26739836
[TBL] [Abstract][Full Text] [Related]
19. Performance of urinary vitamin D-binding protein in diabetic kidney disease: a meta-analysis.
Chen H; Ni L; Wu X
Ren Fail; 2023; 45(2):2256415. PubMed ID: 37870829
[No Abstract] [Full Text] [Related]
20. TNF-α and microalbuminuria in patients with type 2 diabetes mellitus.
Lampropoulou IT; Stangou M; Papagianni A; Didangelos T; Iliadis F; Efstratiadis G
J Diabetes Res; 2014; 2014():394206. PubMed ID: 25587544
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
